drugset / Trial / NCT01914692

Application of Somatostatin for Advanced Gastric Cancer After D2 Lymph Node Dissection

NCT01914692

RandomizedParallel-groupTriple-blindTreatment

Summary

Gastric cancer radical surgery related complications are common.Somatostatin is a conventional medical therapy for bleeding.This study explore the effect of Somatostatin for Advanced Gastric Cancer After D2 Lymph Node dissection.

Timeline

Start
2013-01
Primary completion
2013-07
Completion
2013-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Somatostatin Traditional medicine (herbal / TCM)

Indications

No indication recorded.